Jim Lagopoulos

Honorary Professor at ANU School of Medicine and Psychology; CEO and Executive Director of Brain & Mind Hub and Thompson Brain and Mind Healthcare

Papers

5 publications

Trials

0 clinical trials

Links

Key Impact

He is a leading Australian neuroscience and psychiatry researcher known for neuroimaging and for pioneering oral ketamine studies in chronic suicidality, PTSD, and depression.

Background & Research

Jim Lagopoulos is an Australian neuroscientist and psychiatrist-research leader whose work has focused on brain imaging, stress, mood disorders, trauma, and novel treatments for mental illness. He has held senior academic roles in Australian institutions and currently serves as CEO and Executive Director of Brain & Mind Hub and Thompson Brain and Mind Healthcare, while also holding an honorary professorship at ANU. His recent research has been especially visible in oral ketamine trials for chronic suicidality and related neurobiological outcomes.

5

Research Papers

View publications →

0

Clinical Trials

Explore trials →

Collaboration Network

1 collaborator· click a node to visit their profile

Full network →